Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Acq. announced
Inv. presentation
|
|
Mirum Pharmaceuticals, Inc. (MIRM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Radovich Peter (COO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 1,425 shares
@ $25.6466, valued at
$36.5k
|
|
| 07/05/2023 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 1,004 shares
@ $25.6466, valued at
$25.7k
|
|
| 07/05/2023 |
4
| Vig Pamela (Head of Research & Development) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 1,425 shares
@ $25.6466, valued at
$36.5k
|
|
| 07/05/2023 |
4
| Howe Jolanda (SVP, Global Controller) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 915 shares
@ $25.6466, valued at
$23.5k
Exercised 1,563 options to buy
@ $0
Exercised 1,042 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 5,498 shares
@ $25.6466, valued at
$141k
|
|
| 06/09/2023 |
4
| GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 14,608 shares
@ $29, valued at
$423.6k
Exercised 14,608 options to buy
@ $2.936, valued at
$42.9k
|
|
| 05/19/2023 |
4
| Radovich Peter (COO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 968 shares
@ $16.9235, valued at
$16.4k
|
|
| 05/19/2023 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 684 shares
@ $16.9235, valued at
$11.6k
|
|
| 05/19/2023 |
4
| Vig Pamela (Head of Research & Development) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 684 shares
@ $16.9235, valued at
$11.6k
|
|
| 05/19/2023 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 1,256 shares
@ $16.9235, valued at
$21.3k
|
|
| 05/04/2023 |
4
| GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 14,608 shares
@ $28, valued at
$409k
Exercised 14,608 options to buy
@ $2.936, valued at
$42.9k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 13,132 shares
@ $25.29, valued at
$332.1k
Sold 11,868 shares
@ $25.29, valued at
$300.1k
Sold 171 shares
@ $25.08, valued at
$4.3k
Sold 155 shares
@ $25.08, valued at
$3.9k
Sold 6,909 shares
@ $24.47, valued at
$169.1k
Sold 6,243 shares
@ $24.47, valued at
$152.8k
|
|
| 06/06/2022 |
4
| Ramasastry Saira (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 34,000 options to buy
@ $23.51, valued at
$799.3k
|
|
| 06/06/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 06/06/2022 |
4
| GREY MICHAEL G (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 06/06/2022 |
4
| Brege Laura (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 06/06/2022 |
4
| Fairey William (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 12,750 options to buy
@ $23.51, valued at
$299.8k
|
|
| 06/06/2022 |
4
| Brosgart Carol L (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 15,583 options to buy
@ $23.51, valued at
$366.4k
|
|
| 06/06/2022 |
4
| Fischer Laurent (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 06/06/2022 |
4
| Heron Patrick J (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 06/06/2022 |
4
| O'Donnell Niall (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $23.51, valued at
$399.7k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Longpre Lara (Chief Development Officer) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 1,454 shares
@ $13.566, valued at
$19.7k
|
|
|
|
|